# Black Flame Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/black-flame-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.blackflame.com.cn
- Latest round: Series A (Oct 19, 2025)
- Investors on record: 2

## About

Based in Shanghai, China and founded in 2017, Black Flame Medical specializes in personalized digital medical solutions by integrating customized digital healthcare and advanced 3D printing technologies.

In April 2021, Black Flame Medical closed series A funding from new investor Shengshan Group. In October 2025, the company closed  series A+ funding from new investor Dongxing Capital Investment Management.

Black Flame Medical provides integrated digital healthcare solutions encompassing equipment, materials, software, and technical services. The core offerings include the production of medical models, surgical guides, custom implants, rehabilitation braces, and orthotics, tailored to meet individual patient needs. Advanced 3D printing techniques are employed to create personalized orthopedic components, enhancing patient comfort and treatment efficacy. Their services cater to various medical fields, including orthopedics, plastic surgery, dentistry, and minimally invasive surgery, primarily serving hospitals and medical institutions across China. End users of these products include healthcare professionals and patients requiring specialized medical devices for improved health outcomes. 

Revenue at Black Flame Medical is generated through service provision and product sales, typically involving partnerships with healthcare institutions and direct transactions with medical facilities. The sales encompass clinical medical devices and technical services, including initial consultations, custom product design, and ongoing support. Their tailored solutions reflect the specific needs of clients, with flagship offerings including personalized surgical guides and custom implants, indicating a focus on high-value, specialized products. The company primarily engages in B2B transactions, forming strategic collaborations with hospitals and medical centers to deliver their medical solutions directly to patient care teams.

## Funding rounds

- Series A, Oct 19, 2025 — Dongxing Capital Investment Management
- Angel, Mar 25, 2018 — Shanghai Jianyi Private Equity Fund Management

## Investors

- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Angel
- Dongxing Capital Investment Management (https://capitalatlas.ai/funds/dongxing-capital-investment-management) — Series A